EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference61 articles.
1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998
2. Effects of intensive glucose lowering in type 2 diabetes;Gerstein;N Engl J Med,2008
3. 10-Year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008
4. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes;Hayward;N Engl J Med,2015
5. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality;Nissen;Arch Intern Med,2010
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prolonged impacts of sodium glucose cotransporter-2 inhibitors on metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a retrospective analysis through magnetic resonance imaging;Endocrine Journal;2024
2. Effect of Intensive Glycemic Control on Myocardial Infarction Outcome in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis;Journal of Diabetes Research;2023-02-24
3. Current possibilities of influencing the main cardiovascular risk factors in patients with type 2 diabetes mellitus;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2022-12-27
4. Benefits of SGLT2 inhibitors combining with renin–angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis;Medicina Clínica (English Edition);2022-07
5. Benefits of SGLT2 inhibitors combining with renin–angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis;Medicina Clínica;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3